1-2 of 2
Yoshinori Mano
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Aberrant Expression and Potency as a Cancer Immunotherapy Target of Inhibitor of Apoptosis Protein Family, Livin/ML-IAP in Lung Cancer

Hiroyuki Hariu, Yoshihiko Hirohashi, Toshihiko Torigoe, Hiroko Asanuma, Midori Hariu, Yasuaki Tamura, Katsuyuki Aketa, Chika Nabeta, Katsuya Nakanishi, Kenjiro Kamiguchi, Yoshinori Mano, Hiroshi Kitamura, Junichi Kobayashi, Tomohide Tsukahara, Noriharu Shijubo, Noriyuki Sato
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (3): 1000–1009.
https://doi.org/10.1158/1078-0432.1000.11.3
Published: 11 February 2005
View article titled, Aberrant Expression and Potency as a Cancer Immunotherapy Target of Inhibitor of Apoptosis Protein Family, Livin/ML-IAP in Lung Cancer
Open the PDF for Aberrant Expression and Potency as a Cancer Immunotherapy Target of Inhibitor of Apoptosis Protein Family, Livin/ML-IAP in Lung Cancer in another window
Journal Articles

Gains of 1q21–q22 and 13q12–q14 Are Potential Indicators for Resistance to Cisplatin-based Chemotherapy in Ovarian Cancer Patients

Kazuya Kudoh, Masashi Takano, Tomoyuki Koshikawa, Misako Hirai, Sadao Yoshida, Yoshinori Mano, Kenji Yamamoto, Kenji Ishii, Tsunekazu Kita, Yoshihiro Kikuchi, Ichiro Nagata, Masanao Miwa, Kazuhiko Uchida
Journal: Clinical Cancer Research
Clin Cancer Res (1999) 5 (9): 2526–2531.
Published: 01 September 1999
View article titled, Gains of 1q21–q22 and 13q12–q14 Are Potential Indicators for Resistance to Cisplatin-based Chemotherapy in Ovarian Cancer Patients
Open the PDF for Gains of 1q21–q22 and 13q12–q14 Are Potential Indicators for Resistance to Cisplatin-based Chemotherapy in Ovarian Cancer Patients in another window